Team:British Columbia/humanpractices/GMOLabeling
From 2013.igem.org
(Difference between revisions)
(→GMO Regulation Timeline) |
(→GMO Regulation Timeline) |
||
Line 15: | Line 15: | ||
<br> | <br> | ||
<b>1982</b> | <b>1982</b> | ||
- | <li>The U.S. Food and Drug Administration approves the first genetically engineered drug Humulin, a form of human insulin produced by recombinant E. coli bacteria. Prior to the development of synthesized human insulin, patients were dependent on animal insulin, which was more costly, less accessible, and sometimes caused infection. Humulin is identical in chemical structure to human insulin. | + | <li>The U.S. Food and Drug Administration (FDA) approves the first genetically engineered drug Humulin, a form of human insulin produced by recombinant E. coli bacteria. Prior to the development of synthesized human insulin, patients were dependent on animal insulin, which was more costly, less accessible, and sometimes caused infection. Humulin is identical in chemical structure to human insulin. |
<br> | <br> | ||
<b>1983</b> | <b>1983</b> | ||
Line 27: | Line 27: | ||
<br> | <br> | ||
<b>1992</b> | <b>1992</b> | ||
- | <li>The U.S. Department of Agriculture approves the "Flavr Savr" tomato strain, intended to be resistant to softening and consequent rotting, as the first genetically engineered food to be granted a license for human consumption. Production ceased in 1997 due to poor crop | + | <li>The U.S. Department of Agriculture approves the "Flavr Savr" tomato strain, intended to be resistant to softening and consequent rotting, as the first genetically engineered food to be granted a license for human consumption. Production ceased in 1997 due to poor crop yields and high mounting costs. |
- | + | <br> | |
- | <li>The FDA declares that genetically engineered foods are “not inherently dangerous” and do not require special safety testing or specific | + | <li>The FDA declares that genetically engineered foods are “not inherently dangerous” and do not require special safety testing or specific regulations. This is because they align more with the category of “whole foods”, which the FDA does not oversee, rather than “food products.” |
<br> | <br> | ||
<b>1994</b> | <b>1994</b> | ||
Line 35: | Line 35: | ||
<br> | <br> | ||
<b>1997 </b> | <b>1997 </b> | ||
- | <li>FlavrSavr tomatoes are taken off the market due to increased competition from longer-lasting, conventional varieties. | + | <li>FlavrSavr tomatoes are taken off the U.S. food market due to increased competition from longer-lasting, conventional varieties. |
- | + | <br> | |
- | <li>Requirements for labeling of novel foods and ingredients, those that have not been used for human consumption | + | <li>Requirements for labeling of novel foods and ingredients, those that have not been used for human consumption in the EU, are outlined. The labels are required to include characteristics and materials which may affect the health of some individuals and materials that give rise to ethical concerns. |
- | + | <br> | |
- | <li>After the delivery of unlabelled | + | <li>After the delivery of unlabelled genetically engineered soybeans from the US to European ports, Greenpeace-led activists protest in front of multinational food companies across Europe. As media attention intensifies, Austria and Italy refuse GMO imports and France suspends all GMO imports until regulatory legislation can be reviewed. |
- | + | <br> | |
<li>The FDA Modernization Act is signed into law and streamlines the FDA’s procedures relating to the regulation of food, drugs, devices and biological products. Critics fear the legislation will encourage more crop deregulation. | <li>The FDA Modernization Act is signed into law and streamlines the FDA’s procedures relating to the regulation of food, drugs, devices and biological products. Critics fear the legislation will encourage more crop deregulation. | ||
<br> | <br> |
Revision as of 01:08, 29 October 2013
iGEM Home
Contents |
GMO Labeling
GMO Regulation Timeline
1972
1974
1976
1982
1983
1986
1987
1992
1994
1997
1998
1999
2000
2001
2003
2004
1998 - 2004
2010
Regulations in Place
Voluntary: Canada and US
Mandatory: EU, Australia, the Czech Republic, Hong Kong, and Russia, Japan, South Korea, and Taiwan
Arguments For and Against GMO Labeling
Pro-labeling Arguments
Anti-labeling Arguments
Labeling Recommendations
Purpose:
Language:
Include:
Regulations: